COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Capital B confirms the acquisition of 6 BTC for EUR 0.4 million, the holding of a total of 2,943 BTC, and a BTC Yield of 1.61% YTD
Capital B completes capital increase at €0.65/share, acquires 6 BTC. Achieves BTC Yield of 1.61% YTD. Holds 2,943 BTC valued at €270.5M. Details on Bitcoin Treasury Company strategy available -
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: CANCOM SE: Termination of the 2025 share buyback programme, cancellation of treasury shares and capital reduction
CANCOM SE terminates 2025 share buyback program, cancels treasury shares, and reduces capital ahead of Annual General Meeting. Insider info disclosed in accordance with MAR -
COMMUNIQUÉ DE PRESSE
Mutares enters next phase of growth: Record-breaking pipeline on both the buy and sell sides meets strong results and maximum capital market support
Mutares SE & Co. KGaA announces record-breaking growth phase with strong results, significant exit pipeline, and successful capital increase amid capital market support -
COMMUNIQUÉ DE PRESSE
OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101) for Prevention of Organ Rejection in Heart Transplant Patients
OSE Immunotherapeutics welcomes FDA Orphan Drug Designation granted to Pegrizeprument (VEL-101) for prevention of organ rejection in heart transplant patients, a novel immunomodulatory treatment developed in partnership with Veloxis Pharmaceuticals -
-
COMMUNIQUÉ DE PRESSE
FORVIA: CHANGES TO THE COMPOSITION OF THE BOARD OF DIRECTORS OF FORVIA SUBJECT TO APPROVAL BY THE 2026 ANNUAL GENERAL MEETING
FORVIA announces changes in Board of Directors composition with Pierre-André de Chalendar appointment and resignation of Michel de Rosen. Details on the 2026 Annual General Meeting -
